新型冠状病毒肺炎药物治疗研究进展  

Research progress in drug therapy for coronavirus disease 2019

作　　者：李毅[1] 崔艳慧 潘频华[1] 郑智远[1] LI Yi;CUI Yan-hui;PAN Pin-hua;ZHENG Zhi-yuan(Department of Respiratory and Critical Care Medicine,Xiangya Hospital,Central South University,Changsha 410008,China)

机构地区：[1]中南大学湘雅医院呼吸与危重症医学科,湖南长沙410008

出　　处：《中国感染控制杂志》2020年第10期945-950,共6页Chinese Journal of Infection Control

基　　金：国家重点研发计划(2016YFC1304204、2018YFC1311900);湖南省科技创新计划项目(S2018SFYLJS0108)。

摘　　要：目前,尚未有确认对新型冠状病毒肺炎有效的抗病毒治疗与疫苗预防手段。结合以往冠状病毒治疗的循证证据及临床一线治疗经验制定治疗方案,现就新型冠状病毒肺炎药物治疗研究进展进行综述,具体从核苷逆转录酶抑制剂、核苷类似物等抗病毒药物,以及恢复期血浆治疗等方面进行介绍。Effective antiviral therapy and vaccine preventive measure for coronavirus disease 2019(COVID-19)is still not ascertained at present.Combined with the previous evidence and therapeutic plan formulated based on clinical first-line therapeutic experience of COVID-19,research progress in drug therapy for COVID-19 was reviewed from the aspect of antiviral drugs such as nucleoside reverse transcriptase inhibitors and nucleoside analogues,as well as convalescent plasma therapy.

关 键 词：新型冠状病毒肺炎 新型冠状病毒 药物治疗 研究进展 

分 类 号：R563.1[医药卫生—呼吸系统]